P. Pinsky

R. Hayes, B. Kramer, J. Weissfeld, 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Reye's syndrome and aspirin. Evidence for a dose-response effect.

P. Pinsky, L. Schonberger, W. Gunn, 1988 .

Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.

J. Gohagan, P. Prorok, J. Weissfeld, 2005, Journal of the National Cancer Institute.

Relationships between dioxins in soil, air, ash, and emissions from a municipal solid waste incinerator emitting large amounts of dioxins.

P. Pinsky, M. Lorber, D. Winters, 1998, Chemosphere.

25- to 30-nm virus particle associated with a hospital outbreak of acute gastroenteritis with evidence for airborne transmission.

L. Sawyer, R. Glass, P. Pinsky, 1988, American journal of epidemiology.

Opioid use by cancer status and time since diagnosis among older adults enrolled in the Prostate, Lung, Colorectal, and Ovarian screening trial in the United States

P. Pinsky, S. Strassels, D. Durham, 2021, Cancer medicine.

Other- and All-Cause Mortality Among Men Diagnosed with Prostate Cancer in the PLCO Trial.

H. Parnes, P. Pinsky, E. Miller, 2020, The Journal of urology.

Synchrony measures for biological neural networks

John Rinzel, Paul F. Pinsky, J. Rinzel, 1995, Biological Cybernetics.

Aspirin use and ovarian cancer risk using extended follow-up of the PLCO Cancer Screening Trial.

N. Freedman, P. Pinsky, B. Trabert, 2020, Gynecologic oncology.

Recommendations Related to Genetic Testing for Breast Cancer.

P. Pinsky, 2020, JAMA.

Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer.

S. Berndt, T. Riley, P. Pinsky, 2015, Gastroenterology.

Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study.

P. Choyke, H. Parnes, W. Linehan, 2021, European urology oncology.

Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.

P. Prorok, J. Rathmell, E. Crawford, 2012, Journal of the National Cancer Institute.

Five-year risk of colorectal neoplasia after negative colonoscopy.

P. Pinsky, R. Schoen, 2008, The New England journal of medicine.

Artificial Intelligence and Data Mining to Assess Lung Cancer Risk: Challenges and Opportunities

P. Pinsky, 2020, Annals of Internal Medicine.

Cost-effectiveness of CT screening in the National Lung Screening Trial.

P. Pinsky, 2015, The New England journal of medicine.

Estimating overdiagnosis in lung cancer screening--reply.

B. Kramer, P. Pinsky, E. Patz, 2014, JAMA Internal Medicine.

Relationship between detection of adenomas by flexible sigmoidoscopy and interval distal colorectal cancer.

Shari S. Rogal, P. Pinsky, R. Schoen, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

THORACIC IMAGING: Variability in Nodule Detection Rates at Chest CT in the National Lung Screening

E. Kazerooni, P. Pinsky, D. Gierada, 2013 .

Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial.

P. Prorok, R. Hayes, B. Kramer, 2007, American journal of epidemiology.

Examining the relationship between diabetes and prostate cancer through changes in screening guidelines

Eric A. Miller, P. Pinsky, 2020, Cancer Causes & Control.

Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial

H. Parnes, G. Andriole, P. Pinsky, 2014, BJU international.

Association of Nonadherence to Cancer Screening Examinations With Mortality From Unrelated Causes: A Secondary Analysis of the PLCO Cancer Screening Trial

P. Pinsky, Dudith Pierre-Victor, 2019, JAMA internal medicine.

Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force

William Hazelton, Jihyoun Jeon, Rafael Meza, 2014, Annals of Internal Medicine.

Differences in the relationship between diabetes and prostate cancer among Black and White non-Hispanic men

Eric A. Miller, P. Pinsky, Dudith Pierre-Victor, 2021, Cancer Causes & Control.

Patterns of finasteride and dutasteride use in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial cohort: effects of socio-demographic factors and a black box warning

H. Parnes, P. Pinsky, D. Martin, 2022, Journal of Men's Health.

Colorectal Cancer Screening.

P. Pinsky, Maryam Doroudi, 2016, JAMA.

Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

P. Prorok, B. Kramer, C. Berg, 2010, Clinical trials.

The Lung Screening Study: The National Cancer Institute's Randomized Feasibility Study of Spiral CT versus Chest X-ray in Lung Cancer Screenin

P. Prorok, P. Kvale, P. Pinsky, 2003 .

Power of a Trial Investigating a Low-Intensity PSA-Based Screening Intervention.

P. Pinsky, 2018, JAMA.

PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies.

Thomas M. Riley, P. Prorok, R. Hoover, 2015, Reviews on recent clinical trials.

Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

David A Lynch, John K Gohagan, Carl R Fuhrman, 2010, Journal of the National Cancer Institute.

The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer

Eric A. Miller, P. Pinsky, Dudith Pierre-Victor, 2018, Cancer Causes & Control.

Active follow-up versus passive linkage with cancer registries for case ascertainment in a cohort.

P. Prorok, P. Pinsky, A. Black, 2016, Cancer epidemiology.

Sex Steroid Hormone Metabolism in Relation to Risk of Aggressive Prostate Cancer

Tamra E. Meyer, R. Hoover, T. Veenstra, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials

H. Parnes, E. Crawford, G. Andriole, 2013, Cancer.

One Year Recurrence of Aberrant Crypt Foci

S. Dry, J. Fleshman, D. Seligson, 2010, Cancer Prevention Research.

GSTM1, GSTT1, and GSTP1 Polymorphisms and Risk of Advanced Colorectal Adenoma

R. Hayes, S. Chanock, N. Chatterjee, 2005, Cancer Epidemiology Biomarkers & Prevention.

Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

B. Kramer, S. Buys, D. Reding, 2003, American journal of epidemiology.

The National Lung Screening Trial: Results stratified by demographics, smoking history, and lung cancer histology

B. Kramer, T. Church, G. Izmirlian, 2013, Cancer.

National Lung Screening Trial Findings by Age: Medicare-Eligible Versus Under-65 Population

B. Kramer, P. Pinsky, D. Gierada, 2014, Annals of Internal Medicine.

Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial.

P. Prorok, P. Hu, M. Oken, 2013, Lung cancer.

Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening.

H. Parnes, G. Andriole, P. Pinsky, 2021, Urology.

Extended follow‐up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial

Eric A. Miller, P. Prorok, E. Crawford, 2018, BJU international.

More on Reevaluating PSA Testing Rates in the PLCO Trial.

P. Prorok, P. Pinsky, 2016, The New England journal of medicine.

Factors Associated with the Risk of Adenoma Recurrence in Distal and Proximal Colon

Chyke A Doubeni, P. Pinsky, P. Marcus, 2013, Digestion.

Relationship of demographic and clinical factors to free and total prostate-specific antigen.

J. Gohagan, R. Hayes, B. Kramer, 2001, Urology.

Number of Adenomas Removed and Colorectal Cancers Prevented in Randomized Trials of Flexible Sigmoidoscopy Screening.

P. Pinsky, M. Bretthauer, G. Hoff, 2018, Gastroenterology.

Contribution of Surveillance Colonoscopy to Colorectal Cancer Prevention.

P. Pinsky, R. Schoen, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Antioxidant supplementation and cancer prevention.

P. Pinsky, 2009, JAMA.

Meat, meat cooking methods and preservation, and risk for colorectal adenoma.

R. Sinha, M. Kulldorff, R. Hayes, 2005, Cancer research.

Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities.

Adeyinka O Laiyemo, P. Prorok, Chyke A Doubeni, 2010, Journal of the National Cancer Institute.

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

E. Feuer, H. D. de Koning, Ruth Etzioni, 2017, Annals of Internal Medicine.

Breast Cancer Characteristics and Survival among Users versus Nonusers of Raloxifene

Eric A. Miller, L. Minasian, P. Pinsky, 2019, Cancer Prevention Research.

An evaluation of three empirical air-to-leaf models for polychlorinated dibenzo-p-dioxins and dibenzofurans.

P. Pinsky, M. Lorber, 2000, Chemosphere.

Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial

J. Gohagan, P. Prorok, B. Kramer, 2008, BJU international.

Point estimates of number needed to treat/screen are insufficient without characterization of their uncertainty.

P. Pinsky, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Disease Manifestation among Homosexual Men with Acquired Immunodeficiency Syndrome: A Possible Role of Nitrites in Kaposi's Sarcoma

P. Pinsky, D. Bregman, H. Haverkos, 1985, Sexually transmitted diseases.

Comment on “Systematic review and meta-analysis by Dube et al.”

P. Pinsky, 2018, The American Journal of Gastroenterology.

Neurological and neuropshychological manifestations of HIV‐1 infection: Association with AIDS‐related complex but not asymptomatic HIV‐1 infection

A. Saykin, G. Rutherford, R. Janssen, 1989, Annals of neurology.

Neurological complications of human immunodeficiency virus infection in patients with lymphadenopathy syndrome

A. Saykin, R. Janssen, G. Sprehn, 1988, Annals of neurology.

Cervical cancer screening and predictors of screening by diabetes status

Eric A. Miller, P. Pinsky, 2022, Cancer Causes & Control.

Diarrheal deaths in American children. Are they preventable?

R. Glass, P. Pinsky, L. Anderson, 1988, JAMA.

Effect of flexible sigmoidoscopy on colorectal cancer incidence and mortality: long-term follow-up of the randomized US PLCO Cancer Screening Trial

Eric A. Miller, P. Prorok, T. Church, 2019 .

Multi-Cancer Early Detection Tests: Current Progress and Future Perspectives.

L. Minasian, P. Pinsky, A. Umar, 2022, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Survival Following Detection of Stage I Lung Cancer by Screening in the National Lung Screening Trial

P. Pinsky, D. Gierada, 2021 .

Beneﬁts and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force

Summer S. Han, E. Feuer, S. Plevritis, 2014 .

Rotavirus as a cause of diarrheal morbidity and mortality in the United States.

R. Glass, P. Pinsky, L. Anderson, 1988, The Journal of infectious diseases.

Laboratory detective work identifies a mishandling problem in sample aliquoting.

P. Pinsky, M. Purdue, Claire S Zhu, 2014, Biopreservation and biobanking.

15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality

Eric A. Miller, H. Adami, P. Pinsky, 2022, Annals of Internal Medicine.

Colorectal Cancer Screening: Randomized Trials Are Essential to Support Recommendations

P. Pinsky, M. Bretthauer, R. Schoen, 2021, Annals of Internal Medicine.

The IARC Perspective on Colorectal Cancer Screening.

P. Pinsky, L. Rabeneck, B. Lauby-Secretan, 2018, The New England journal of medicine.

Lung cancer among workers in chromium chemical production.

P. Pinsky, P. Lees, P. Lees, 2000, American journal of industrial medicine.

Intrinsic and network rhythmogenesis in a reduced traub model for CA3 neurons

John Rinzel, Paul F. Pinsky, J. Rinzel, 2004, Journal of Computational Neuroscience.

The Effect of the Thyroid on the Formation of the Hen’s Egg

P. Pinsky, V. Asmundson, 1935 .

Inter-rater agreement on chromosome 5 breakage in FISH-based mutagen sensitivity assays (MSAs).

P. Pinsky, P. Wagner, P. Barker, 2004, Mutation research.

A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause?

P. Pinsky, L. Schonberger, J. Kaplan, 1987, JAMA.

Heterosexual and homosexual patients with the acquired immunodeficiency syndrome. A comparison of surveillance, interview, and laboratory data.

P. Pinsky, H. Jaffe, G. Noble, 1984, Annals of internal medicine.

Abnormalities on chest radiograph reported in subjects in a cancer screening trial.

M. Oken, P. Kvale, P. Pinsky, 2006, Chest.

Community outbreak of thyrotoxicosis: epidemiology, immunogenetic characteristics, and long-term outcome.

P. Pinsky, L. Anderson, D. Lawrence, 1988, The American journal of medicine.

Clinical findings of irritation among chromium chemical production workers.

P. Pinsky, P. Lees, H. Gibb, 2000, American journal of industrial medicine.

Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens

Sudhir Srivastava, Steven J Skates, Mark D Thornquist, 2011, Cancer Prevention Research.

The natural history of aberrant crypt foci.

S. Dry, D. Seligson, P. Pinsky, 2008, Gastrointestinal endoscopy.

Association of Colonoscopy Adenoma Findings With Long-term Colorectal Cancer Incidence

P. Pinsky, R. Schoen, Maryam Doroudi, 2018, JAMA.

A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer

Sudhir Srivastava, David F. Ransohoff, Martin W. McIntosh, 2011, Cancer Prevention Research.

Lung cancer screening with low-dose CT: a world-wide view.

P. Pinsky, Paul F Pinsky, 2018, Translational lung cancer research.

Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?

C. Berg, P. Pinsky, Christine D Berg, 2012, Journal of medical screening.

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

Mark P Purdue, Barnett S Kramer, John K Gohagan, 2012, The New England journal of medicine.

Methods for etiologic and early marker investigations in the PLCO trial.

Robert N Hoover, Ulrike Peters, Paul Pinsky, 2005, Mutation research.

Lung Cancer Risk Associated With New Solid Nodules in the National Lung Screening Trial.

R. Munden, P. Pinsky, D. Gierada, 2017, AJR. American journal of roentgenology.

MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis.

P. Choyke, H. Parnes, W. Linehan, 2020, The New England journal of medicine.

Prognostic factors for hematologic cancers.

P. Pinsky, S. Srivastava, R. Misra, 2000, Hematology/oncology clinics of North America.

Injuries and poisonings in out-of-home child care and home care.

P. Pinsky, L. Schonberger, J. Sacks, 1991, American journal of diseases of children.

Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening

Paul Pinsky, P. Pinsky, E. Szabo, 2018, Chest.

Occurrence of Distal Colorectal Neoplasia Among Whites and Blacks Following Negative Flexible Sigmoidoscopy: An Analysis of PLCO Trial

P. Prorok, Chyke A Doubeni, J. Weissfeld, 2015, Journal of General Internal Medicine.

Rabies surveillance, United States, 1987.

P. Pinsky, D. Fishbein, J. Dobbins, 1988, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.

R. Hayes, N. Chatterjee, K. McGlynn, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Rabies surveillance, United States, 1988.

T. Eng, P. Pinsky, J. Dobbins, 1989, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

A six-year follow-up of HIV-infected homosexual men with lymphadenopathy. Evidence for an increased risk for developing AIDS after the third year of lymphadenopathy.

P. Pinsky, L. Schonberger, T. Spira, 1988, JAMA.

Unexplained lymphadenopathy in homosexual men. A longitudinal study.

P. Pinsky, L. Schonberger, T. Spira, 1985, JAMA.

Lymphadenopathy syndrome in homosexual men. Evidence for continuing risk of developing the acquired immunodeficiency syndrome.

P. Pinsky, L. Schonberger, T. Spira, 1987, JAMA.

Assessment of risk from long term exposure to waterborne pathogens

Paul F. Pinsky, P. Pinsky, 2000, Environmental and Ecological Statistics.

Definition of Specificity in a Screening Trial.

P. Pinsky, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening.

B. Kramer, P. Pinsky, 2015, Journal of the National Cancer Institute.

Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

H. Parnes, G. Andriole, D. Reding, 2012, Cancer epidemiology.

Prostate Cancer Screening - A Perspective on the Current State of the Evidence.

P. Prorok, B. Kramer, P. Pinsky, 2017, The New England journal of medicine.

Improving Research on Biomarkers for Early Detection and Screening of Cancers

C. Berg, P. Pinsky, Claire S Zhu, 2012 .

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.

J. Gohagan, P. Prorok, B. Kramer, 2005, Journal of the National Cancer Institute.

Evaluation of Aspirin Use With Cancer Incidence and Survival Among Older Adults in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

P. Pinsky, A. Umar, Holli A. Loomans-Kropp, 2021, JAMA network open.

Extended mortality results for prostate cancer screening in the PLCO trial with median follow‐up of 15 years

J. Gohagan, P. Prorok, B. Kramer, 2017, Cancer.

Deep Learning for Lung Cancer Detection in Screening CT Scans: Results of a Large-Scale Public Competition and an Observer Study with 11 Radiologists

P. K. Gerke, B. van Ginneken, P. Pinsky, 2021, Radiology: Artificial Intelligence.

Public Health Service study of Reye's syndrome and medications. Report of the main study.

P. Pinsky, R. Kaslow, L. Schonberger, 1987, JAMA.

GWAS Explorer: an open-source tool to explore, visualize, and access GWAS summary statistics in the PLCO Atlas

S. Chanock, M. García-Closas, Norma A. Diaz-Mayoral, 2023, Scientific Data.

Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial.

N. Chatterjee, P. Pinsky, P. Langenberg, 2008, Archives of internal medicine.

Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

J. Gohagan, P. Pinsky, P. Marcus, 2008, Journal of the National Medical Association.

Prevalence of non-cancer-related abnormalities on low-dose spiral computer tomography versus chest radiograph in a screening population

M. Oken, P. Kvale, P. Pinsky, 2007, Thorax.

Baseline Characteristics of Participants in the Randomized National Lung Screening Trial

Denise R. Aberle, Paul F. Pinsky, David A. Lynch, 2010, Journal of the National Cancer Institute.

Validation of Biomarker Panels for Ovarian Cancer A Framework for Evaluating Biomarkers for Early Detection : Updated

R. Bast, E. Fung, P. Hartge, 2011 .

Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial National Lung Screening Trial Writing Team 1.

Eric A. Miller, T. Church, P. Pinsky, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Comparing Benefits from Many Possible Computed Tomography Lung Cancer Screening Programs: Extrapolating from the National Lung Screening Trial Using Comparative Modeling

Summer S. Han, E. Feuer, S. Plevritis, 2014, PloS one.

Racial and ethnic differences in lung cancer incidence: how much is explained by differences in smoking patterns? (United States)

P. Pinsky, 2006, Cancer Causes & Control.

Prediction of True Positive Lung Cancers in Individuals with Abnormal Suspicious Chest Radiographs—A Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Study

P. Prorok, P. Hu, C. Berg, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Utilization of surveillance colonoscopy in community practice.

R. Hayes, C. Berg, J. Weissfeld, 2010, Gastroenterology.

Impact of comorbidity and age on treatment choice among men with localized prostate cancer.

W. McCaskill-Stevens, P. Pinsky, R. Grubb, 2019, Journal of Clinical Oncology.

The yield of surveillance colonoscopy by adenoma history and time to examination.

P. Prorok, J. Weissfeld, L. Yokochi, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Prostate volume and prostate-specific antigen levels in men enrolled in a large screening trial.

J. Gohagan, B. Kramer, G. Andriole, 2006, Urology.

Low-Dose CT Screening for Lung Cancer: Evidence from 2 Decades of Study.

D. Yankelevitz, P. Pinsky, D. Gierada, 2020, Radiology. Imaging cancer.

A model to evaluate past exposure to 2,3,7,8-TCDD.

P. Pinsky, M. Lorber, 1998, Journal of exposure analysis and environmental epidemiology.

Modeling the Effect of a Preventive Intervention on the Natural History of Cancer: Application to the Prostate Cancer Prevention Trial

Paul F. Pinsky, Nadia Howlader, Ruth Etzioni, 2006 .

Results of repeat sigmoidoscopy 3 years after a negative examination.

J. Gohagan, P. Prorok, J. Weissfeld, 2003, JAMA.

Healthcare Access, Utilization, and Preventive Health Behaviors by Eligibility for Lung Cancer Screening

Eric A. Miller, P. Pinsky, 2019, Journal of Cancer Education.

Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study.

P. Pinsky, A. Schatzkin, R. Schoen, 2010, Gastrointestinal endoscopy.

Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial.

P. Pinsky, A. Schatzkin, P. Marcus, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

A gonorrhea model treating sensitive and resistant strains in a multigroup population.

R. Shonkwiler, P. Pinsky, 1990, Mathematical biosciences.

Overall mortality in men and women in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Eric A. Miller, P. Prorok, P. Pinsky, 2019, Journal of medical screening.

Incidental Findings on Low-Dose CT Lung Cancer Screenings and Deaths from Respiratory Diseases.

P. Pinsky, D. Gierada, D. Lynch, 2021, Chest.

Repeat prostate biopsy in the Prostate, Lung, Colorectal and Ovarian cancer screening trial

J. Gohagan, B. Kramer, E. Crawford, 2007, BJU international.

Does hereditary nonpolyposis colorectal cancer explain the observed excess risk of colorectal cancer associated with family history?

P. Pinsky, 2000, Epidemiology.

Metastatic prostate cancer at diagnosis and through progression in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

R. Hoover, H. Parnes, G. Andriole, 2019, Cancer.

Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta

P. Pinsky, R. Osarogiagbon, N. Faris, 2023, JAMA network open.

Potential Disparities by Sex and Race or Ethnicity in Lung Cancer Screening Eligibility Rates.

Chyke A Doubeni, P. Pinsky, Y. Lau, 2021, Chest.

Survival After Detection of Stage I Lung Cancer by Screening in the National Lung Screening Trial.

P. Pinsky, D. Gierada, 2020, Chest.

Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps

Jasmin A. Tiro, M. Khoury, D. Winn, 2016, Cancer Epidemiology, Biomarkers & Prevention.

Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

P. Prorok, J. Weissfeld, T. Church, 2012, Gastrointestinal endoscopy.

Breast Cancer Screening Trials: Endpoints and Over-diagnosis.

P. Pinsky, I. Jatoi, 2020, Journal of the National Cancer Institute.

Why Does Magnetic Resonance Imaging-Targeted Biopsy Miss Clinically Significant Cancer?

H. Parnes, P. Pinsky, P. Pinto, 2021, The Journal of urology.

Breast cancer risk prediction models and subsequent tumor characteristics

Eric A. Miller, L. Minasian, P. Pinsky, 2020, Breast Cancer.

Likelihood of missed and recurrent adenomas in the proximal versus the distal colon.

Chyke A Doubeni, P. Pinsky, A. Schatzkin, 2011, Gastrointestinal endoscopy.

An epidemic of acute hemorrhagic conjunctivitis in American Samoa caused by coxsackievirus A24 variant.

L. Sawyer, P. Pinsky, M. Pallansch, 1989, American journal of epidemiology.

Prostate‐specific antigen velocity and prostate cancer gleason grade and stage

J. Gohagan, E. Crawford, G. Andriole, 2007, Cancer.

598 Factors Associated with Distal and Proximal Adenoma Recurrence Among Participants in the Polyp Prevention Trial

Chyke A Doubeni, P. Pinsky, A. Schatzkin, 2009 .

Use of raloxifene and tamoxifen by breast cancer risk level in a Medicare‐eligible cohort

Eric A. Miller, L. Minasian, P. Pinsky, 2018, American journal of obstetrics and gynecology.

The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: Performance and complications

Barnett S Kramer, B. Kramer, P. Pinsky, 2017, Journal of medical screening.

Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants

E. Kazerooni, D. Aberle, P. Pinsky, 2017, European Radiology.

Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.

Fenghai Duan, Paul Pinsky, Denise R Aberle, 2014, Journal of the National Cancer Institute.

Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.

B. Kramer, C. Gatsonis, D. Aberle, 2016, The Lancet. Oncology.

Healthcare Access, Utilization, and Preventive Health Behaviors by Eligibility for Lung Cancer Screening

Eric A. Miller, P. Pinsky, 2019, Journal of Cancer Education.

The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource

P. Lenz, R. Hoover, Amy Miller, 2016, Cancer Epidemiology, Biomarkers & Prevention.

The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource.

J. Gohagan, P. Prorok, B. Kramer, 2013, Journal of the National Cancer Institute.

Lung cancer risk by years since quitting in 30+ pack year smokers

B. Kramer, P. Pinsky, Claire S Zhu, 2015, Journal of medical screening.

CLINICAL—ALIMENTARY TRACT Utilization of Surveillance Colonoscopy in Community Practice

R. Hayes, C. Berg, J. Weissfeld, 2010 .

tilization of Surveillance Colonoscopy in Community Practice

C. Berg, J. Weissfeld, T. Church, 2022 .

Assessing the benefits and harms of low-dose computed tomography screening for lung cancer.

P. Pinsky, 2014, Lung cancer management.

Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up.

J. Gohagan, P. Prorok, B. Kramer, 2016, Gynecologic oncology.

An Early‐ and Late‐Stage Convolution Model for Disease Natural History

P. Pinsky, 2004, Biometrics.

Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals

P. Pinsky, P. Castle, H. Katki, 2023, JAMA network open.

Long-term cancer risk associated with lung nodules observed on low-dose screening CT scans.

P. Pinsky, D. Gierada, 2019, Lung cancer.

Lung Cancer Mortality in the Lung Screening Study Feasibility Trial

P. Pinsky, P. Marcus, Maryam Doroudi, 2018, JNCI Cancer Spectrum.

Estimating stage-specific sensitivity for cancer screening tests

Jane M Lange, Ruth Etzioni, P. Pinsky, 2023, Journal of medical screening.

Data sharing in clinical trials: An experience with two large cancer screening trials

Thomas M. Riley, P. Prorok, J. Rathmell, 2017, PLoS medicine.

Screening for cancer: lessons learned from the prostate, lung, colorectal, and ovarian cancer screening trial.

P. Prorok, G. Andriole, P. Pinsky, 2015, European urology.

Reader Variability in Identifying Pulmonary Nodules on Chest Radiographs From the National Lung Screening Trial

David Lynch, Paul Pinsky, Colleen Sanders, 2012, Journal of thoracic imaging.

Thyroid incidentalomas in association with low-dose computed tomography in the National Lung Screening Trial.

B. Kramer, P. Pinsky, B. Dunn, 2019, American journal of epidemiology.

Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial

Eric A. Miller, G. Andriole, P. Pinsky, 2018, The Prostate.

Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival.

Eric A. Miller, L. Minasian, C. Berg, 2017, European journal of cancer.

Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial.

Barnett S Kramer, John K Gohagan, J. Gohagan, 2005, The Journal of urology.

Screening for Prostate Cancer.

H. Parnes, P. Pinsky, 2023, The New England journal of medicine.

Opioid and Other Medication Use and General Health Status in a Cohort of Older Adults

P. Pinsky, S. Strassels, D. Durham, 2021, Gerontology.

Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy.

J. Gohagan, R. Hayes, J. Weissfeld, 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial.

Thomas M. Riley, J. Gohagan, P. Prorok, 2015, Reviews on recent clinical trials.

Intrinsic and network rhythmogenesis in a reduced traub model for CA3 neurons

John Rinzel, Paul F. Pinsky, J. Rinzel, 1995, Journal of Computational Neuroscience.

Beyond the AJR: Larger and More Diverse Lung Cancer Screening Population Expected After Expansion of Recommended Eligibility Criteria by U.S. Preventive Services Task Force.

P. Pinsky, D. Gierada, 2022, AJR. American journal of roentgenology.

Electronic Health Records and Machine Learning for Early Detection of Lung Cancer and Other Conditions: Thinking about the Path Ahead

P. Pinsky, 2021, American journal of respiratory and critical care medicine.

ROC Curves for Low-Dose CT in the National Lung Screening Trial

E. Kazerooni, P. Pinsky, D. Gierada, 2013, Journal of medical screening.

Use and Outcomes of Low-Dose CT Lung Cancer Screening in the Medicare Population.

Eric A. Miller, P. Pinsky, 2022, Chest.

Lung Cancer Screening Benefits and Harms Stratified by Patient Risk: Information to Improve Patient Decision Aids

P. Pinsky, David P. Miller, C. Bellinger, 2019, Annals of the American Thoracic Society.

Incidental renal tumours on low-dose CT lung cancer screening exams

B. Kramer, R. Munden, P. Pinsky, 2017, Journal of medical screening.

False-positive screens and lung cancer risk in the National Lung Screening Trial: Implications for shared decision-making

P. Pinsky, David P. Miller, C. Bellinger, 2017, Journal of medical screening.

Emphysema Detection in the Course of Lung Cancer Screening: Optimizing a Rare Opportunity to Impact Population Health

G. Washko, S. Armato, M. Oudkerk, 2022, Annals of the American Thoracic Society.

Prostate specific antigen changes as related to the initial prostate specific antigen: data from the prostate, lung, colorectal and ovarian cancer screening trial.

J. Gohagan, B. Kramer, E. Crawford, 2006, The Journal of urology.

Principles of Cancer Screening.

P. Pinsky, 2015, The Surgical clinics of North America.

Yield of advanced adenoma and cancer based on polyp size detected at screening flexible sigmoidoscopy.

J. Weissfeld, T. Riley, P. Pinsky, 2006, Gastroenterology.

Scaling of True and Apparent ROC AUC with Number of Observations and Number of Variables

Paul F. Pinsky, P. Pinsky, 2005 .

Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci.

S. Dry, D. Seligson, P. Pinsky, 2009, Gastrointestinal endoscopy.

A multicenter study of prevalence and risk factors for aberrant crypt foci.

S. Dry, J. Fleshman, D. Seligson, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

A two-region nonequilibrium model for solute transport in solution conduits in karstic aquifers

Malcolm S. Field, P. Pinsky, M. Field, 2000 .

The relationship of cancer characteristics and patient outcome with time to lung cancer diagnosis after an abnormal screening CT

R. Munden, P. Pinsky, D. Gierada, 2017, European Radiology.

Does the evidence support the implementation of lung cancer screening with low-dose computed tomography?

P. Pinsky, 2018, Expert review of respiratory medicine.

Commentary on "Screening for lung cancer" by Sateia et al.

P. Pinsky, 2017, Seminars in oncology.

Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy.

P. Prorok, Chyke A Doubeni, C. Berg, 2012, Cancer epidemiology.

Estimation and Prediction for Cancer Screening Models Using Deconvolution and Smoothing

P. Pinsky, 2001, Biometrics.

Effect of screening on ovarian cancer mortality in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer randomized screening trial.

P. Prorok, J. Rathmell, P. Hartge, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality

Eric A. Miller, H. Adami, P. Pinsky, 2022, Annals of Internal Medicine.

Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.

Eric A. Miller, P. Prorok, T. Church, 2019, The lancet. Gastroenterology & hepatology.

The efficacy of prostate‐specific antigen screening: Impact of key components in the ERSPC and PLCO trials

E. Feuer, H. D. de Koning, Ruth Etzioni, 2018, Cancer.

Colorectal , and Ovarian Cancer Screening Trial Specimens Ovarian Cancer Biomarker Performance in Prostate , Lung , Updated

R. Bast, P. Hartge, C. Berg, 2011 .

Erratum: Lung cancer among workers in chromium chemical production (American Journal of Industrial Medicine (2000) 38 (115-126))

P. Pinsky, P. Lees, H. Gibb, 2000 .

Re: The carcinogenicity risk assessment of chromium compounds

P. Pinsky, P. Lees, H. Gibb, 2004 .

Serum Prostate-Specific Antigen Hemodilution Among Obese Men Undergoing Screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

P. Prorok, E. Crawford, C. Berg, 2009, Cancer Epidemiology Biomarkers & Prevention.

Joan Rivers and the Spectacle of Defacement: Comedy, Plastic Surgery, and the Red Carpet Freakshow

P. Pinsky, 2015 .

General population screening for ovarian cancer

P. Pinsky, B. Trabert, L. Hurwitz, 2021, The Lancet.

Can symptomatic cancer be distinguished from screen detected cancer?

P. Pinsky, R. Schoen, 2014, Gastroenterology.

Understanding early-onset colorectal cancer: The role of obesity.

P. Pinsky, A. Laiyemo, 2022, Gastroenterology.

Estimating Rates of True High-Grade Disease in the Prostate Cancer Prevention Trial

H. Parnes, L. Ford, P. Pinsky, 2008, Cancer Prevention Research.

Risk factors associated with echovirus 11' infection in a hospital nursery

P. Pinsky, W. Martone, L. Anderson, 1986, Pediatric infectious disease.

M1989 Performance of High Magnification Colonoscopy (HMc) in Detecting Aberrant Crypt Foci (ACF)

P. Pinsky, R. Schoen, M. Mutch, 2008 .

Diagnostic procedures after a positive spiral computed tomography lung carcinoma screen

P. Kvale, D. Reding, P. Pinsky, 2005, Cancer.

Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

D. Lynch, J. Gohagan, P. Prorok, 2010, Journal of the National Cancer Institute.

Screening in the randomized Prostate , lung , colorectal , and Ovarian ( PlcO ) cancer Screening trial

D. Lynch, J. Gohagan, P. Prorok, 2010 .

Lung Nodule Malignancy Prediction in Sequential CT Scans: Summary of ISBI 2018 Challenge

Lubomir M. Hadjiiski, Gabriel Bernardino, Hichem Frigui, 2021, IEEE Transactions on Medical Imaging.

Early detection versus primary prevention in the PLCO flexible sigmoidoscopy screening trial: Which has the greatest impact on mortality?

P. Pinsky, R. Schoen, Maryam Doroudi, 2017, Cancer.

Results of the Cancer Screening Feasibility Study in China: A Multicentered Randomized Controlled Trial of Lung and Colorectal Cancer Screening

P. Prorok, P. Hu, Jie He, 2021, Journal of the National Cancer Center.

Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial.

Paul Pinsky, Stuart G Baker, Barnett S Kramer, 2010, Biostatistics.

Short- and Long-term Lung Cancer Risk Associated with Noncalcified Nodules Observed on Low-Dose CT

P. Pinsky, D. Gierada, E. Szabo, 2014, Cancer Prevention Research.

Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens

R. Bast, P. Hartge, C. Berg, 2011, Cancer Prevention Research.

Re: Is the area under an ROC curve a valid measure of the performance of a screening or diagnostic test?

P. Pinsky, 2014, Journal of medical screening.

Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial

J. Gohagan, P. Prorok, B. Kramer, 2008, BJU international.

Prostate Cancer Screening - A Perspective on the Current State of the Evidence.

P. Prorok, B. Kramer, P. Pinsky, 2017, The New England journal of medicine.

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.

J. Gohagan, P. Prorok, B. Kramer, 2005, Journal of the National Cancer Institute.

Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.

D. Aberle, P. Pinsky, D. Gierada, 2014, Journal of the National Cancer Institute.

False-positive screens and lung cancer risk in the National Lung Screening Trial: Implications for shared decision-making

P. Pinsky, David P. Miller, C. Bellinger, 2017, Journal of medical screening.

Neurological symptoms and neuropsychological abnormalities in lymphadenopathy syndrome

A. Saykin, R. Janssen, G. Sprehn, 1988, Annals of neurology.

Diagnostic follow‐up of indeterminate pulmonary nodules in the Medicare population

P. Pinsky, R. Osarogiagbon, 2023, Cancer.

Mortality results from a randomized prostate-cancer screening trial.

A. Miller, J. Gohagan, P. Prorok, 2009, The New England journal of medicine.

Changes in uptake of stool-based colorectal cancer screening during the Covid-19 pandemic

Eric A. Miller, P. Pinsky, 2023, Cancer Causes and Control.

Flexible sigmoidoscopy screening: is once enough?

P. Pinsky, 2017, The Lancet.

Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps

Jasmin A. Tiro, D. Winn, A. Zauber, 2016, Cancer Epidemiology, Biomarkers & Prevention.

Colorectal cancer incidence by age among patients undergoing surveillance colonoscopy.

P. Pinsky, R. Schoen, 2015, JAMA internal medicine.

Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.

J. Gohagan, P. Prorok, J. Rathmell, 2011, JAMA.

Pulmonary Nodules, Lung Cancer Screening and Lung Cancer in the Medicare Population.

Eric A. Miller, P. Pinsky, R. Osarogiagbon, 2022, Chest.

Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

D. Lynch, J. Gohagan, P. Prorok, 2010, Journal of the National Cancer Institute.

Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy.

P. Prorok, Chyke A Doubeni, J. Weissfeld, 2012, Cancer epidemiology.

Breast Cancer Screening Trials: Endpoints and Overdiagnosis

P. Pinsky, I. Jatoi, Ismail Jatoi, 2021 .

Incidental renal tumours on low-dose CT lung cancer screening exams

R. Munden, P. Pinsky, D. Gierada, 2017, Journal of medical screening.

The relationship of cancer characteristics and patient outcome with time to lung cancer diagnosis after an abnormal screening CT

R. Munden, P. Pinsky, D. Gierada, 2017, European Radiology.

Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening.

N. Fineberg, P. Pinsky, D. Gierada, 2011, Radiology.